On this page
Quick Reference
Overview and Recommendations
Background
- •The serum osmolal gap (OG) is the difference between directly measured serum osmolality (by freezing point depression) and calculated osmolarity using sodium, urea, glucose, and ethanol. It flags the presence of unmeasured osmotically active solutes, most critically toxic alcohols.
- •Two types exist: the serum OG for toxic alcohol screening and the urine osmolal gap (UOG) for evaluating renal tubular acidosis. The serum OG is the focus of this page; the UOG is used to estimate urine ammonium in hyperchloremic metabolic acidosis.
- •Untreated methanol or ethylene glycol poisoning carries mortality > in some series; early recognition and treatment with fomepizole and hemodialysis can be life-saving. The OG is the most accessible surrogate marker when confirmatory levels are not immediately available.
- •Several calculation formulas exist; the simplified equation 2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol (all in mmol/L) is the most accurate, with 95% of normal values between -10.9 and 13.8 mOsm/kg. This formula improves diagnostic accuracy for toxic alcohol exposure compared with older published equations.
- •A critical pitfall: a normal OG does not exclude toxic alcohol poisoning. In a pediatric outbreak of diethylene glycol intoxication, the mean OG was only 3.46 ± 4.68 mOsm/kg yet mortality was 37.5%. The OG must never be used alone to rule out poisoning.
Evaluation
- •Suspect toxic alcohol ingestion in any patient with unexplained high anion gap metabolic acidosis (HAGMA), visual disturbances, altered mental status, or acute kidney injury. Calculate the osmolal gap using the simplified formula as the first bedside step.
- •Ask about the timing of ingestion, co-ingestion of ethanol, specific symptoms (visual blurring with methanol, flank pain with ethylene glycol), history of alcohol abuse (alcoholic ketoacidosis), exposure to medical drugs (propylene glycol from continuous IV lorazepam or pentobarbital), and product details (hand sanitizer, antifreeze, syrup medications in children).
- •Examine for vital signs, mental status, pupillary response (methanol can cause dilated pupils and papilledema), CNS depression, fruity breath odor (isopropanol), and signs of acute kidney injury. Visual symptoms are a red flag for methanol poisoning.
- •Order serum osmolality (freezing point), electrolytes (Na, K, Cl, HCO3), BUN, glucose, ethanol level, arterial blood gas, lactate, and send methanol and ethylene glycol levels. Also order urinalysis for oxalate crystals (ethylene glycol) and ketones (isopropanol, AKA).
- •Diagnostic criteria: an elevated OG ≥10 mOsm/kg with HAGMA is classic for methanol or ethylene glycol. Isopropanol causes elevated OG with ketosis but no metabolic acidosis. Alcoholic ketoacidosis (AKA) presents with elevated OG and HAGMA but resolves with volume repletion and dextrose.
- •Also consider non-toxic causes: diabetic ketoacidosis, alcoholic ketoacidosis, chronic kidney disease, multiple myeloma (paraproteins), pseudohyponatremia (from hyperproteinemia or hyperlipidemia), and propylene glycol toxicity (iatrogenic from IV lorazepam/pentobarbital). The OG can be elevated in these conditions and mimic toxic alcohol poisoning.
- •Red flags: visual symptoms mandate urgent ophthalmology consultation and antidote initiation; acute kidney injury with calcium oxalate crystals requires immediate hemodialysis; profound bradyarrhythmia in a patient on high-dose lorazepam suggests propylene glycol toxicity and may require dialysis.
Management
- •Initiate 15 mg/kg IV loading dose, then 10 mg/kg every 12 hours for 4 doses, then 15 mg/kg every 12 hours if needed (dose per standard protocol; adjust for hemodialysis). Start empirically when toxic alcohol poisoning is suspected, ideally within 1 hour of presentation, without waiting for confirmatory levels.
- •If fomepizole is unavailable, administer IV to achieve a serum ethanol level of 100-150 mg/dL. Ethanol requires frequent monitoring of serum levels and has a narrower therapeutic window; it is less well tolerated than fomepizole.
- •Initiate for severe poisoning: pH <7.2, osmolal gap >50 mOsm/kg, methanol or ethylene glycol levels >50 mg/dL, visual symptoms, acute kidney injury, or refractory acidosis. Target hemodialysis initiation within 4-6 hours of diagnosis. In methanol poisoning, the OG correlates closely with serum methanol during dialysis (y=1.09x+3.82; R²=0.92) and can guide dialysis duration, potentially reducing dialysis time by 34%.
- •Monitor serum OG, anion gap, arterial blood gas, electrolytes, and renal function every 2-4 hours during therapy. The OG should decline as the toxic alcohol is metabolized or removed. If the gap fails to decrease or acidosis worsens, reassess for ongoing absorption, inadequate dialysis, or an alternative diagnosis such as propylene glycol or alcoholic ketoacidosis.
- •Continue fomepizole until toxic alcohol levels are undetectable or below toxic thresholds. For isopropanol poisoning, no specific antidote exists; management is supportive with airway support and hemodialysis reserved for life-threatening cases with CNS depression or circulatory collapse.
- •What NOT to do: Do not delay hemodialysis while awaiting confirmatory toxic alcohol levels if clinical criteria are met. Do not rely solely on the OG to rule out poisoning; a normal gap does not exclude it, especially in late presenters. Do not administer fomepizole without considering non-toxic causes, while empiric use is justified when suspicion is high, 40% of fomepizole administrations are for non-toxic exposures, incurring significant cost.
- •When to refer: Transfer to a dialysis-capable facility if not available on-site. Consult medical toxicology or nephrology early. For intentional ingestions, obtain psychiatric evaluation before discharge. Discharge criteria: resolution of metabolic acidosis (serum bicarbonate ≥20 mmol/L, normal anion gap), normalization of OG (<10 mOsm/kg), no neurologic or visual symptoms, and psychiatric clearance. For low suspicion cases with normal gaps, observe 6-12 hours with serial labs before discharge.
Board Review — High Yield
- •Osmolal gap formula: 2×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol (all in mmol/L), most accurate; normal range -10.9 to 13.8 mOsm/kg
- •Normal gap does not rule out: In diethylene glycol outbreak, mean OG was 3.46 mOsm/kg despite 37.5% mortality
- •Methanol vs ethylene glycol: Both cause high AG acidosis + elevated OG, but methanol causes visual disturbances; ethylene glycol causes oxalate crystalluria and AKI
- •Isopropanol: Elevated OG + ketonemia without acidosis; no antidote, supportive care
- •Propylene glycol: Double gap (high AG + high OG) from high-dose IV lorazepam; treat by stopping drug, consider hemodialysis for severe bradyarrhythmia
- •Alcoholic ketoacidosis: Mimics toxic alcohol poisoning; resolves with fluids and dextrose
- •Pseudohyponatremia: Falsely low Na from hyperproteinemia/hyperlipidemia elevates calculated OG; check direct ISE
- •Fomepizole dose: 15 mg/kg IV loading, then 10 mg/kg q12h; adjust for hemodialysis
- •Hemodialysis indication: pH <7.2, OG >50, methanol/EG >50 mg/dL, end-organ damage
- •OG guides dialysis duration: In methanol, OG correlates with methanol level during dialysis (R²=0.92), can reduce dialysis time by 34%
Deep Dive — Evidence Details
Definition, Classification and Nomenclature
- ▸The serum osmolal gap is calculated as measured osmolality minus calculated osmolarity; an elevated gap suggests unmeasured solutes such as toxic alcohols.
- ▸The urine osmolal gap (UOG) estimates urine ammonium and distinguishes renal tubular acidosis from extrarenal bicarbonate loss.
- ▸Different calculation formulas yield different gap values; the simplified equation 2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol improves diagnostic accuracy for toxic alcohol exposure [1].
The serum osmolal gap is the difference between directly measured serum osmolality and calculated serum osmolarity, a bedside calculation that flags the presence of unmeasured osmotically active solutes in the blood [4]D5[16]D5.
Also Called / Synonyms
- Osmolal gap
- Osmolar gap
- Delta osmolality [16]D5
Classification
Two distinct types of osmolal gap are used in clinical practice, each serving a different diagnostic purpose:
| Type | Calculation | Primary Clinical Use |
|---|---|---|
| Serum osmolal gap (SOG) | Measured serum osmolality - calculated osmolarity (using Na⁺, urea, glucose, ± ethanol) | Screening for toxic alcohol poisoning (methanol, ethylene glycol, isopropanol, diethylene glycol, propylene glycol) [1]B3b[5]D5[8]D5[9]D5[12]C4[14]C4 |
| Urine osmolal gap (UOG) | Measured urine osmolality - [2(Na⁺ + K⁺) + urea + glucose] | Estimating urine ammonium concentration; differentiating renal tubular acidosis from extrarenal bicarbonate loss in [2]B3b[2]B3b[2]B3b[18]D5 |
Within the serum osmolal gap, multiple calculation formulas exist. The choice of equation directly affects the gap value and diagnostic accuracy. A simplified formula derived from a large cohort, 2.0 × Na + 1.2 × Urea + 1.4 × Glucose + 1.2 × Ethanol (all in mmol/L), yielded 95% of osmolal gap values between -10.9 and 13.8 and demonstrated superior diagnostic accuracy for toxic alcohol exposure compared with older published equations [1]B3b. Adjustment of bias in published equations can generate usable formulas with osmolal gap reference limits within ±10 mOsm/kg [19]D5.
Clinical Significance
The serum osmolal gap is a cornerstone screening tool in emergency medicine and toxicology. An elevated gap raises suspicion for toxic alcohol ingestion, especially when combined with a high anion gap metabolic acidosis [3]D5[11]C4. However, the gap can be normal in some toxic alcohol exposures, particularly early after ingestion or when ethanol is co-ingested, limiting its sensitivity as a standalone test [8]D5[10]C4[14]C4. The urine osmolal gap, by contrast, is the preferred method to assess renal acidification; a UOG <150 mosmol/kg in a patient with hyperchloremic acidosis and preserved renal function indicates renal tubular acidosis, while a UOG >150 mosmol/kg suggests extrarenal bicarbonate loss [2]B3b.
The mechanisms that generate an elevated osmolal gap, and the pitfalls that can obscure it, are discussed in the next section.
Pearl: Different calculation formulas yield different gap values; the simplified equation 2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol improves diagnostic accuracy for toxic alcohol exposure [1]B3b.
Mechanisms of the Dangerous Differential
- ▸The differential for an elevated osmolal gap includes toxic alcohols, alcoholic ketoacidosis, lactic acidosis, and pseudohyponatremia.
- ▸Methanol and ethylene glycol require immediate empiric treatment while awaiting confirmatory levels.
- ▸Propylene glycol toxicity should be considered in ICU patients receiving continuous sedative infusions.
From the definition of the osmolal gap as the difference between measured and calculated osmolality, the clinical imperative shifts immediately to identifying which unmeasured osmole is responsible, because the answer determines a life-or-death intervention. The differential for an elevated osmolal gap is narrow but includes several conditions that require radically different management: toxic alcohol ingestions, alcoholic ketoacidosis, lactic acidosis, and pseudohyponatremia.
Comparison Table of Dangerous Differentials
| Condition | Mechanism of Osmolal Gap | Key Lab Findings | Clinical Clues | How to Rule Out |
|---|---|---|---|---|
| Parent alcohol (methanol) itself | High AG metabolic acidosis, increased OG, possible visual disturbances | Visual symptoms, history of ingestion | Measure methanol level | |
| Parent alcohol (ethylene glycol) | High AG metabolic acidosis, increased OG, oxalate crystalluria, AKI | Calcium oxalate crystals, flank pain, CNS depression | Measure ethylene glycol level | |
| Parent alcohol and acetone | Increased OG, ketonemia/ketonuria, no metabolic acidosis, normal AG | Fruity odor, CNS depression, no acidosis | Measure isopropanol level | |
| Parent compound (PG) | High AG metabolic acidosis, increased OG, elevated lactate, hyperosmolality | History of PG-containing drugs (lorazepam, pentobarbital) | Measure PG level, drug history | |
| Ketones (acetoacetate, β-hydroxybutyrate) | High AG metabolic acidosis, increased OG, ketonemia, history of heavy alcohol use | Recent binge, vomiting, starvation | Measure β-hydroxybutyrate, response to fluids/dextrose | |
| Lactate (unmeasured anion) | High AG metabolic acidosis, increased OG, elevated lactate | Tissue hypoxia, sepsis, , seizures | Measure lactate, identify cause | |
| Falsely low Na → falsely low calculated osmolality | Low measured Na, normal measured osmolality, elevated protein or lipids | Hyperproteinemia (HIV/HCV), hyperlipidemia | Direct ISE Na, check protein/lipids |
When to Suspect Each Alternative
Suspect or in any patient with unexplained high anion gap metabolic acidosis and elevated osmolal gap, especially with visual symptoms (methanol) or oxalate crystalluria and acute kidney injury (ethylene glycol) [21]C4[22]D5. should be considered when an elevated osmolal gap is accompanied by ketonemia and ketonuria without metabolic acidosis, often with CNS depression and a fruity odor [9]D5[22]D5. toxicity arises in hospitalized patients receiving continuous infusions of lorazepam or pentobarbital, presenting with double gap metabolic acidosis and elevated lactate [23]C4[27]C4. occurs in chronic alcoholics after a binge with poor oral intake, presenting with high AG acidosis and ketosis that resolves with fluids and dextrose [22]D5[24]C4. is common in critically ill patients and can elevate the osmolal gap; it should not be dismissed as the sole cause when toxic alcohol ingestion is possible [21]C4. from hypergammaglobulinemia or hyperlipidemia produces an elevated osmolal gap due to a falsely low calculated osmolality; suspect in patients with HIV/HCV coinfection or nephrotic syndrome [25]C4.
Must-Not-Miss Differentials
- Methanol ingestion: Can cause blindness and death; rule out with serum methanol level and early treatment with fomepizole or ethanol and hemodialysis [22]D5.
- Ethylene glycol ingestion: Leads to acute kidney injury and severe acidosis; rule out with serum ethylene glycol level and urine oxalate crystals [21]C4.
- Propylene glycol toxicity: Iatrogenic cause of double gap acidosis; rule out by reviewing drug history and measuring PG level [23]C4[27]C4.
When to Reconsider the Diagnosis
Reopen the differential if the osmolal gap does not narrow with treatment of the presumed cause, if the anion gap acidosis worsens despite appropriate therapy, or if the clinical picture does not fit the expected toxidrome. For example, a patient with presumed lactic acidosis who does not have an obvious cause (sepsis, ischemia) should prompt measurement of toxic alcohols [21]C4. Similarly, an elevated osmolal gap in a patient with normal measured osmolality and low sodium suggests pseudohyponatremia rather than a true osmole [25]C4.
Pearl: When a high anion gap metabolic acidosis and elevated osmolal gap coexist, treat empirically for methanol or ethylene glycol poisoning while awaiting confirmatory levels, the window for preventing end-organ damage is measured in hours, not days [22]D5.
Epidemiology, Etiology and Risk Factors
- ▸Elevated serum osmolal gap is a key screening tool for toxic alcohol poisoning, but a normal gap does not exclude it, in one outbreak mean gap was 3.46 despite confirmed EG/DEG intoxication [10].
- ▸Hyperchloremic acidosis occurs in 43% of critically ill patients, and renal tubular acidosis is highly prevalent (72%) in that subgroup, often requiring urine osmolal gap analysis [2].
- ▸Risk factors for toxic alcohol poisoning include ingestion of adulterated syrup-based medications, especially in children; no specific risk factors for RTA in critical illness were identified in multivariate analysis [2,10].
The mechanisms of the dangerous differential explain how unmeasured osmoles generate the gap, but the clinical utility of the serum osmolal gap depends on knowing when to suspect it and how commonly it is elevated. The most frequent clinical scenario prompting calculation of the serum osmolal gap is suspected toxic alcohol poisoning, yet the epidemiology of this finding is surprisingly sparse in the published literature.
Incidence and Prevalence
In a pediatric outbreak of acute kidney injury linked to ethylene glycol (EG) and diethylene glycol (DEG) intoxication in Indonesia, 16 patients tested positive for EG and DEG, all with a history of consuming syrup-based medications [10]C4. Despite confirmed intoxication, the mean serum osmolal gap was 3.46 ± 4.68, well within the normal range, demonstrating that a normal gap does not exclude toxic alcohol poisoning [10]C4. Mortality in this cohort was 37.5% (6 of 16 patients) [10]C4.
In critically ill adults, , a condition often evaluated with the urine osmolal gap, occurred in 43% of patients on at least one day during the first week of ICU admission [2]B3b. Among those with hyperchloremic acidosis, 31 of 43 (72%) had renal tubular acidosis (RTA) defined by a urine osmolal gap <150 mosmol/kg and preserved renal function [2]B3b. The majority (23 of 31) had proximal (type II) RTA, while 8 had distal (type I) RTA [2]B3b. These data highlight that acid-base disturbances requiring osmolal gap analysis are common in the ICU.
Etiologies
The serum osmolal gap is elevated by unmeasured osmotically active substances. The classic causes include:
- Toxic alcohols: methanol, ethylene glycol, diethylene glycol, isopropanol [5]D5[10]C4
- Ketoacidosis: diabetic ketoacidosis, alcoholic ketoacidosis [3]D5
- [3]D5
- Renal failure (accumulation of unmeasured anions) [2]B3b
- Other: , overdose, acetaminophen overdose [5]D5
Importantly, the presence of an osmolal gap is not pathognomonic for any single etiology; clinical context and additional laboratory parameters (anion gap, urine pH, serum potassium) are required for differentiation [3]D5.
Risk Factors
Risk factors for conditions that elevate the serum osmolal gap are derived from the underlying disease processes. For toxic alcohol poisoning, the primary risk factor is ingestion of adulterated products. In the Indonesian outbreak, all 16 children had consumed syrup-based medications, implicating contaminated pharmaceutical preparations as a major risk factor [10]C4. Industrial exposure, accidental ingestion in children, and intentional overdose in adults are other well-recognized risks [5]D5.
For hyperchloremic acidosis and RTA in critically ill patients, a multivariate analysis including diabetes, , chronic kidney disease, congestive heart failure, liver cirrhosis, neuroleptic drugs, muscle relaxants, combined antibiotic schemes, plasmapheresis, and sedoanalgesia found no variables were predictive for the presence of RTA [2]B3b. This suggests that the risk is diffuse across the critically ill population rather than concentrated in specific subgroups.
Seasonal Variation
No seasonal variation is reported in the provided evidence.
Special Considerations
- Post-infection timing: The Indonesian outbreak did not correspond to a rise in incidence, suggesting that the AKI surge was toxin-related rather than infection-driven [10]C4.
- Vaccine-related risk: No association with vaccination is reported.
Pearl: A normal serum osmolal gap does not rule out ethylene glycol or diethylene glycol intoxication, in one outbreak the mean gap was 3.46, yet all patients had confirmed poisoning and mortality was 37.5% [10]C4.
| Etiology | Key Evidence | Prevalence/Incidence |
|---|---|---|
| Ethylene glycol / Diethylene glycol intoxication | 16 children with confirmed EG/DEG; mean osmolal gap 3.46 [10]C4 | Outbreak setting; mortality 37.5% [10]C4 |
| Methanol intoxication | Mentioned as classic cause [5]D5 | Not reported |
| Isopropanol intoxication | Mentioned as classic cause [5]D5 | Not reported |
| Diabetic ketoacidosis | Osmolal gap may be elevated [3]D5 | Not reported |
| Alcoholic ketoacidosis | Osmolal gap may be elevated [3]D5 | Not reported |
| Lactic acidosis | Osmolal gap may be elevated [3]D5 | Not reported |
| Renal failure | Unmeasured anions accumulate [2]B3b | Not reported |
| Salicylate poisoning | Mentioned as cause [5]D5 | Not reported |
| Metformin overdose | Mentioned as cause [5]D5 | Not reported |
| Acetaminophen overdose | Mentioned as cause [5]D5 | Not reported |
Clinical Presentation
- ▸The osmolal gap may be normal in early or late presentations of toxic alcohol poisoning; a high index of suspicion is required even when the gap is not elevated [10,22].
- ▸Visual symptoms in methanol poisoning are a red flag for irreversible optic nerve damage and mandate immediate antidote therapy [14].
- ▸Isopropanol poisoning presents with an elevated osmolal gap and ketonemia without metabolic acidosis, distinguishing it from other toxic alcohols [9].
The clinical presentation of an elevated serum osmolal gap is inseparable from the underlying cause, most often toxic alcohol ingestion, and the timing of presentation relative to exposure determines which laboratory abnormalities dominate. The classic picture of methanol or ethylene glycol poisoning combines a high anion gap metabolic acidosis with an elevated osmolal gap, but either can be absent depending on the time after exposure when blood is sampled [22]D5. Isopropanol poisoning, by contrast, produces an elevated osmolal gap with ketonemia and ketonuria but no metabolic acidosis [9]D5. Non-toxic causes, including diabetic or alcoholic ketoacidosis, acute kidney injury, chronic kidney disease, , and , can also elevate the osmolal gap and must be considered in the differential [30]C4[35]C4.
Presenting Symptoms
Symptoms reflect the specific alcohol ingested and its metabolites:
- Methanol: Abdominal pain and visual disturbances (blurred vision, photophobia, blindness) appear a few hours to a few days after exposure [14]C4. Nausea and vomiting are nearly universal [32]D5.
- Ethylene glycol: Early inebriation followed by acute kidney injury, often with flank pain and oliguria. Calcium oxalate crystals may be seen in urine [31]C4.
- Isopropanol: CNS depression ranging from drowsiness to coma, with a fruity or sweet odor on the breath. Respiratory depression and circulatory collapse occur in severe cases [9]D5.
- Propylene glycol: Double gap metabolic acidosis (high anion gap + high osmolal gap) with severe bradyarrhythmia, typically in the setting of continuous lorazepam infusion [23]C4.
- Diethylene glycol: Rapidly progressive acute kidney injury in children, often with history of syrup-based medication consumption [10]C4.
Neurological Examination Findings
Neurologic signs are prominent in several toxic alcohol poisonings:
- Methanol: Visual acuity loss, papilledema, and altered mental status. In one series, 31% of admissions had specific visual complaints and 40% had intoxication or altered mental status [32]D5.
- Ethylene glycol: Cranial nerve palsies, nystagmus, and seizures can occur [22]D5.
- Isopropanol: Global CNS depression without focal findings; deep coma may precede respiratory arrest [9]D5.
- Propylene glycol: Sedation out of proportion to the clinical setting, often in ICU patients receiving high-dose benzodiazepines [23]C4.
Phenotypic Variants
| Toxic Alcohol | Key Features | Typical Lab Findings | Frequency/Notes |
|---|---|---|---|
| Methanol | Visual symptoms, abdominal pain | pH <7.35 (93%), HCO3 <20 mEq/L (96%), OG ≥10 mOsm/L (81%), AG >16 (69%) [32]D5 | Common in among older Native American men [32]D5 |
| Ethylene glycol | Acute kidney injury, calcium oxalate crystals | Median pH 7.31, HCO3 15 mmol/L, OG 81 mOsm/kg [31]C4 | Repeated exposures seen in dissociative disorder [31]C4 |
| Isopropanol | CNS depression, fruity breath, ketonemia | OG elevated, no metabolic acidosis, ketonuria [9]D5 | Most exposures unintentional in children [9]D5 |
| Propylene glycol | Double gap metabolic acidosis, bradyarrhythmia | High AG + high OG [23]C4 | Iatrogenic from IV lorazepam [23]C4 |
| Diethylene glycol | Rapidly progressive AKI in children | Mean OG 3.46 ± 4.68 (often normal), high AG metabolic acidosis [10]C4 | Outbreak linked to contaminated syrup [10]C4 |
Red Flags
- Visual symptoms in : urgent ophthalmology consultation and antidote (fomepizole or ethanol) to prevent irreversible blindness [14]C4.
- Acute kidney injury with calcium oxalate crystals: ethylene glycol poisoning requiring hemodialysis [31]C4.
- Severe bradyarrhythmia with double gap acidosis: propylene glycol toxicity; hemodialysis can be life-saving [23]C4.
- Respiratory depression with CNS depression: isopropanol poisoning; airway support is the priority [9]D5.
- Altered mental status with elevated osmolal gap: empiric fomepizole should be administered while awaiting confirmatory testing [17]D5.
Atypical Presentations
- Elevated osmolal gap without metabolic acidosis: Seen in isopropanol poisoning [9]D5 and very early toxic alcohol ingestion before metabolite accumulation [22]D5.
- Metabolic acidosis without elevated osmolal gap: Late presentation after alcohol has been metabolized, or in children with diethylene glycol poisoning where the mean osmolal gap was only 3.46 mOsm/kg [10]C4.
- Elevated osmolal gap from non-toxic causes: Diabetic ketoacidosis, alcoholic ketoacidosis, acute kidney injury, chronic kidney disease, lactic acidosis, and multiple myeloma can all elevate the gap and mimic toxic alcohol poisoning [30]C4[35]C4. In one national poison center study, 40% of fomepizole administrations were for non-toxic alcohol exposures, with ethanol (24.9%) and unknown drugs (17.5%) being the most common mimics [17]D5.
Pearl: When an elevated osmolal gap is encountered, the first question is not 'which toxic alcohol?' but 'is this a toxic alcohol at all?', non-toxic causes such as diabetic ketoacidosis, renal failure, and multiple myeloma account for a substantial proportion of elevated gaps, and empiric fomepizole is administered to many patients who ultimately have other diagnoses [17]D5[35]C4.
The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup
- ▸The simplified formula 2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol improves diagnostic accuracy for toxic alcohol exposure compared to older formulas [1].
- ▸The osmolal gap must be interpreted alongside the anion gap and pH; for methanol, pH has the highest predictive value for mortality (ROC area 0.94) [36].
- ▸The osmolal gap can safely guide the duration of hemodialysis in methanol poisoning when direct methanol levels are unavailable, potentially reducing dialysis time by 34% [37].
When a patient presents with unexplained metabolic acidosis, visual disturbances, or altered mental status, the clinician must immediately consider toxic alcohol poisoning. The serum osmolal gap (OG) is the first-line screening tool, but its interpretation requires a structured, worst-first approach to avoid diagnostic delays.
Worst-First Differential
The can't-miss diagnoses are methanol and ethylene glycol ingestion, both of which cause a high anion gap metabolic acidosis and an elevated OG. Isopropanol poisoning also elevates the OG but produces ketosis without significant acidosis. Other causes of an elevated OG include:
- Diabetic ketoacidosis (DKA)
- Alcoholic ketoacidosis
- Chronic kidney disease (CKD)
- (due to paraproteins)
- Administration of hyperosmolar contrast or mannitol
Each of these must be systematically excluded using the OG in combination with the anion gap, pH, and ethanol level.
Gold-Standard Test
The definitive diagnosis of toxic alcohol poisoning is direct measurement of serum methanol and ethylene glycol concentrations. However, these assays are often not available rapidly, making the OG an essential surrogate. The OG should never be used alone to confirm or exclude poisoning; it must be integrated with clinical and other laboratory data.
Laboratory Studies
Calculating the Osmolal Gap
The OG is the difference between measured osmolality (by freezing point depression) and calculated osmolarity. The choice of formula significantly affects diagnostic accuracy. In a large retrospective study of 7,525 patients, Lepeytre et al. derived a simplified equation that outperformed older formulas: 2.0 × Na + 1.2 × Urea + 1.4 × Glucose + 1.2 × Ethanol (all in mmol/L) [1]B3b. This formula yielded 95% of OG values between -10.9 and 13.8 mOsm/kg in patients without detectable ethanol [1]B3b. In patients with detectable ethanol, the range was similar or narrower [1]B3b.
Anion Gap and pH
The anion gap and arterial pH are critical adjuncts. For , survivors had a mean OG of 48 mOsm/kg (range 6-138) versus 90 mOsm/kg (range 49-159) in non-survivors (p=0.0052); the area under the ROC curve for pH was 0.94 (95% CI 0.89-0.99), the highest among the three biomarkers [36]D5. For ethylene glycol, survivors had a mean OG of 49 mOsm/kg (range 0-189) versus 79 mOsm/kg (range 25-184) in non-survivors (p=0.050); the anion gap had the highest ROC area at 0.73 (95% CI 0.60-0.87) [36]D5.
Ethanol Level
Concurrent ethanol ingestion is common and must be measured because ethanol contributes to the OG and can delay toxic alcohol metabolism. The formula from [1]B3b accounts for ethanol, but the OG must be interpreted in the context of the ethanol level.
Diagnostic Algorithm
Step 1: Calculate the OG using the simplified formula (2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol). An OG ≥10 mOsm/kg raises suspicion, but cutpoints vary; Krahn et al. found that optimal cutpoints ranged from +10 to +33 mOsm/kg depending on the formula used [29]B3b. Step 2: Assess the anion gap and pH. A high anion gap metabolic acidosis with an elevated OG strongly suggests methanol or ethylene glycol. Step 3: Send confirmatory toxic alcohol levels. Step 4: If levels are positive, initiate therapy and determine dialysis need. If negative, search for alternative causes.
Using the Osmolal Gap to Guide Therapy
In methanol poisoning, the OG correlates closely with serum methanol during hemodialysis (y=1.09x+3.82; R²=0.92) [37]D5. This allows the OG to guide both the initiation and duration of dialysis when methanol levels are unavailable. In one outbreak, using the OG to determine dialysis duration would have saved 23 hours (34%) of dialysis time across nine patients [37]D5.
Once the diagnosis is confirmed, the next step is to assess severity and determine the need for hemodialysis (see ).
Pearl: The osmolal gap can safely guide the duration of hemodialysis in methanol poisoning when direct methanol levels are unavailable, potentially reducing dialysis time by 34% [37]D5.
Severity, Risk Stratification and Triage
- ▸Triage for suspected toxic alcohol poisoning relies on the combination of osmolal gap, anion gap, acid-base status, and clinical findings; no single parameter is sufficient.
- ▸A normal osmolal gap does not rule out severe poisoning, as seen in ethylene glycol/diethylene glycol outbreaks where mean osmolal gap was 3.46 mOsm/kg despite high mortality [10].
- ▸Serial measurement of osmolal and anion gaps can track disease progression and guide triage and treatment decisions [15].
The diagnostic sieve identifies patients at risk for toxic alcohol poisoning, but the osmolal gap alone cannot reliably stratify severity; it must be interpreted alongside the anion gap, acid-base status, and clinical findings to determine triage acuity. The combination of these parameters, however, provides a framework for risk stratification that drives the initial triage decision, critical care versus monitored floor versus discharge, and pre-empts the need for antidote and hemodialysis.
The Osmolal Gap as a Severity Marker
The magnitude of the osmolal gap does not directly correlate with clinical severity. In methanol and ethylene glycol poisoning, the osmolal gap is typically elevated early, before significant metabolism has occurred, while the anion gap remains normal. As the alcohol is metabolized to organic acids, the osmolal gap narrows and the anion gap widens [8]D5[14]C4. Thus, a high osmolal gap with a normal anion gap suggests early presentation, whereas a high anion gap with a normal osmolal gap suggests delayed presentation after metabolism has occurred. Both scenarios carry high risk: early cases require prompt antidote to prevent metabolite accumulation, and late cases already have established toxicity. In isopropanol poisoning, an elevated osmolal gap is common but metabolic acidosis is typically absent, reflecting the different toxicokinetics, isopropanol is metabolized to acetone, not to organic acids [9]D5. This distinction is critical for triage: isopropanol poisoning is generally less severe and managed supportively, while methanol and ethylene glycol require ICU-level care.
Triage Based on Clinical and Laboratory Parameters
No single validated score exists for triage in toxic alcohol poisoning, but the following parameters, when present together, indicate high severity and warrant ICU admission:
- High anion gap metabolic acidosis (pH < 7.3, anion gap > 16 mEq/L) [12]C4[14]C4
- Elevated osmolal gap (> 10-15 mOsm/kg, depending on the formula used) [1]B3b[19]D5
- Acute kidney injury (rising creatinine) [17]D5
- CNS depression, visual symptoms, or seizures [14]C4
- Hypotension or respiratory compromise [9]D5
Patients with isolated elevated osmolal gap without acidosis (e.g., isopropanol ingestion) and no significant clinical findings may be triaged to a monitored medical floor or, after a period of observation, considered for discharge if symptoms resolve [9]D5. However, because the osmolal gap can be normal in confirmed toxic alcohol poisoning, as seen in an outbreak of ethylene glycol/diethylene glycol poisoning in children where mean osmolal gap was only 3.46 ± 4.68 mOsm/kg [10]C4, a normal gap does not rule out severe poisoning. In that series, all patients had high anion gap metabolic acidosis (mean anion gap 15.6 ± 7.8 mEq/L) and stage 3 AKI, and mortality was 37.5% [10]C4. Therefore, the anion gap and clinical context must override a normal osmolal gap when suspicion is high.
Limitations and Pitfalls in Triage
Several factors confound the osmolal gap as a triage tool:
- Ethanol co-ingestion: Ethanol itself contributes to the osmolal gap (approximately 0.23 mOsm/kg per mg/dL, or serum ethanol [mg/dL] / 4.6) [20]D5. A patient with ethanol on board may have an elevated osmolal gap from ethanol alone, masking or mimicking toxic alcohol exposure.
- Late presentation: As noted, once the toxic alcohol is metabolized, the osmolal gap normalizes while the anion gap rises [8]D5[14]C4. A normal osmolal gap in a patient with high anion gap metabolic acidosis should raise suspicion for toxic alcohol poisoning, not lower it.
- Non-toxic alcohol causes of elevated osmolal gap: Hypertonic treatments (mannitol, IVIG), diabetic ketoacidosis, and chronic kidney disease can elevate the osmolal gap [4]D5[18]D5. These must be considered in the differential.
- Empiric fomepizole use: In a large US poison center study, fomepizole was administered empirically in 40% of cases that ultimately were not toxic alcohol exposures; these non-toxic alcohol patients actually had higher rates of acidosis, elevated creatinine, anion gap, and osmolal gap than confirmed toxic alcohol patients [17]D5. This underscores that the osmolal gap is not specific and that triage decisions must incorporate the full clinical picture.
Role of Serial Measurements
Serial monitoring of both the osmolal gap and anion gap can help track the evolution of poisoning and guide triage and treatment decisions. In one case of , the osmolal gap rose to 83 mOsm/kg with a concurrent high anion gap of 25.5 mEq/L, prompting hemodialysis; after dialysis, the gaps normalized and the patient recovered [15]C4. Frequent reassessment allows the clinician to adjust the triage level (e.g., from floor to ICU) if the clinical trajectory worsens.
Handoff to Acute Resuscitation
Any patient with suspected toxic alcohol poisoning and evidence of metabolic acidosis, end-organ dysfunction, or significant clinical findings should be triaged to a critical care setting for monitoring, antidote administration (fomepizole or ethanol), and preparation for possible hemodialysis. The next section details the acute resuscitation and stabilization of these patients.
Pearl: The osmolal gap is most useful for triage when interpreted dynamically with the anion gap: a high osmolal gap with a normal anion gap suggests early, treatable poisoning; a high anion gap with a normal osmolal gap suggests delayed, already-toxic poisoning, both require ICU-level care, but the latter may need more urgent hemodialysis.
| Toxic Alcohol | Typical Osmolal Gap | Typical Anion Gap | Acidosis | Triage Level |
|---|---|---|---|---|
| Methanol / Ethylene glycol (early) | Elevated | Normal | Absent or mild | ICU (antidote needed) |
| Methanol / Ethylene glycol (late) | Normal | Elevated | Severe | ICU (hemodialysis likely) |
| Isopropanol | Elevated | Normal | Absent | Monitored floor or observation |
| Diethylene glycol (reported outbreak) | Normal (mean 3.46) | Elevated (mean 15.6) | Present | ICU (high mortality) [10]C4 |
Acute Resuscitation and Stabilization
- ▸Empiric fomepizole should be administered when toxic alcohol poisoning is suspected, without waiting for confirmatory levels [17].
- ▸Hemodialysis is indicated for severe methanol or ethylene glycol poisoning with metabolic acidosis, end-organ damage, or high levels [14].
- ▸For isopropanol poisoning, supportive care is the mainstay; hemodialysis is reserved for severe cases [9].
After triage identifies a patient at risk for toxic alcohol poisoning, resuscitation must begin immediately, often before confirmatory laboratory results are available [12]C4. The MERMAID pathway, Monitoring, Empiric antidote, Resuscitation, Management of airway, Antidote administration, Investigation, Dialysis, provides a structured approach to parallel execution.
ABCDE Resuscitation
Airway protection is the first priority. CNS depression from methanol, ethylene glycol, or isopropanol can impair airway reflexes, and vomiting is common [9]D5[14]C4. Early intubation is indicated for <8 or inability to protect the airway. Breathing support may be required for respiratory depression, particularly with isopropanol poisoning [9]D5. Circulation: establish two large-bore IV lines, obtain blood for osmolality, electrolytes, and toxic alcohol levels, and begin fluid resuscitation. Hypotension may occur from vasodilation or myocardial depression. Disability: assess mental status and pupillary response; methanol can cause visual disturbances [14]C4. Exposure: identify the specific agent from history or product containers.
Antidote Administration
Fomepizole is the drug of choice for methanol and ethylene glycol poisoning. It inhibits alcohol dehydrogenase, preventing formation of toxic metabolites [14]C4. Because confirmatory levels are often delayed, fomepizole should be administered empirically when toxic alcohol poisoning is suspected based on history, elevated osmolal gap, and high anion gap metabolic acidosis [17]D5. Ethanol is an alternative if fomepizole is unavailable, but it requires careful monitoring of serum ethanol levels and has a narrower therapeutic window [14]C4. For isopropanol poisoning, no specific antidote exists; management is supportive [9]D5.
Enhanced Elimination: Hemodialysis
Hemodialysis effectively removes both the parent alcohol and its toxic metabolites. It is indicated for methanol or ethylene glycol poisoning with severe metabolic acidosis (pH <7.25-7.30), end-organ damage (visual symptoms, acute kidney injury), or high serum levels [14]C4. In , hemodialysis also removes formate, the primary toxic metabolite [14]C4. For isopropanol, hemodialysis enhances elimination of isopropanol and acetone but is reserved for severe life-threatening cases with refractory hypotension or deep coma [9]D5. High-flux hemodialysis was used successfully in a case of methanol poisoning with recovery [15]C4.
Supportive Care and Monitoring
Continuous monitoring of vital signs, mental status, and acid-base status is essential. Repeat measurement of osmolal gap and anion gap can track response to therapy [15]C4. Correction of acidosis with sodium bicarbonate may be considered in severe acidemia, though evidence from the provided references is limited. For ethylene glycol poisoning, calcium oxalate crystals can cause acute kidney injury; ensure adequate urine output [10]C4. Mortality remains high even with treatment: in one series of methanol poisoning from hand sanitizer, all five patients died despite fomepizole and hemodialysis [12]C4. Early recognition and rapid intervention are critical.
Once the patient is stabilized, attention turns to definitive airway management and procedural sedation, covered in the next section.
Pearl: In suspected toxic alcohol poisoning, administer fomepizole immediately based on clinical suspicion and surrogate markers (osmolal gap, anion gap, acidosis) without waiting for confirmatory levels, delays increase mortality [12]C4[17]D5.
Resuscitative Procedures, Airway Management & Procedural Sedation
- ▸Emergency hemodialysis is the definitive procedure for removing toxic alcohols and their metabolites; it should be initiated rapidly when criteria are met.
- ▸Fomepizole is the recommended antidote and should be given empirically when toxic alcohol poisoning is suspected, despite its cost and potential for overuse.
- ▸Airway management and mechanical ventilation may be required due to CNS and respiratory depression from severe poisoning.
Once initial stabilization is underway, the focus shifts to definitive interventions that directly address the toxic alcohol or its metabolites. The most critical resuscitative procedure is emergency hemodialysis, which rapidly removes both the parent alcohol and its toxic metabolites. Hemodialysis is indicated for severe methanol or ethylene glycol poisoning, particularly when there is high anion gap metabolic acidosis, end-organ dysfunction (e.g., visual changes, acute kidney injury), or serum concentrations above thresholds (e.g., methanol >50 mg/dL, ethylene glycol >50 mg/dL) [14]C4. In a case series of from contaminated hand sanitizer, two of five patients received emergency extracorporeal therapy, though all five died despite maximal treatment [12]C4. Another report documented successful recovery after 4 hours of high-flux hemodialysis, with serum bicarbonate returning to 23 mmol/L and the patient regaining consciousness [15]C4. For isopropanol poisoning, hemodialysis enhances elimination of both isopropanol and acetone and should be considered in very severe poisoning with CNS or respiratory depression [9]D5. The decision to initiate hemodialysis must be made rapidly, as delays worsen outcomes; transfer to a facility with dialysis capability may be necessary if not available on-site [12]C4.
Antidote Administration
Fomepizole is the recommended antidote for toxic alcohol poisoning and should be administered empirically when the diagnosis is suspected, even before confirmatory testing [14]C4. Fomepizole inhibits alcohol dehydrogenase, preventing formation of toxic metabolites. In a 12-year review of US Poison Center data, fomepizole was used 25,110 times, with 60% of administrations for reported toxic alcohol poisoning; however, use in non-toxic alcohol exposures increased after 2020, reflecting the difficulty of rapid diagnosis [17]D5. The antidote is generally well tolerated, but empiric use in patients without toxic alcohol exposure carries significant cost (estimated $1.5-$2.5 million over the study period) [17]D5. Ethanol is an alternative inhibitor but is less commonly used due to its own adverse effects and need for frequent monitoring [14]C4.
Airway and Respiratory Support
Severe poisoning often leads to CNS and respiratory depression, necessitating definitive airway management. In isopropanol poisoning, the major features are CNS depression, respiratory depression, shock, and circulatory collapse [9]D5. Patients with depressed consciousness or inability to protect the airway should undergo rapid sequence intubation. Procedural sedation for intubation should be performed with agents that minimize hemodynamic compromise, such as etomidate or ketamine, though specific sedation protocols are not addressed in the reviewed evidence. Mechanical ventilation may be required to manage acid-base disturbances and protect the airway until the toxic alcohol is cleared.
What NOT to Do
- Do not delay hemodialysis while awaiting confirmatory toxic alcohol levels if clinical suspicion is high and criteria are met [14]C4.
- Do not rely solely on the osmolal gap to rule out toxic alcohol exposure; a normal gap does not exclude poisoning, especially if presentation is delayed or ethanol is co-ingested [8]D5.
- Do not administer fomepizole without considering the possibility of non-toxic alcohol causes, as this leads to unnecessary cost and resource use [17]D5.
Pearl: In suspected toxic alcohol poisoning, initiate fomepizole empirically and prepare for emergency hemodialysis if severe acidosis or end-organ dysfunction is present; do not wait for confirmatory levels, as timely intervention is lifesaving [14]C4[15]C4.
| Indication | Evidence Source |
|---|---|
| Severe metabolic acidosis (high anion gap) | [14]C4 |
| End-organ dysfunction (visual changes, AKI) | [14]C4 |
| Serum methanol or ethylene glycol >50 mg/dL | [14]C4 |
| Severe isopropanol poisoning with CNS/respiratory depression | [9]D5 |
| Lack of response to supportive care | [12]C4 |
Definitive ED Therapy, Time-to-Intervention Targets & Handoff
- ▸Empiric fomepizole should be given within 1 hour of suspected toxic alcohol poisoning, before confirmatory levels return.
- ▸Hemodialysis is indicated for severe poisoning (pH <7.2, osmolal gap >50, renal failure, visual symptoms) and should be initiated within 4-6 hours.
- ▸Structured handoff to ICU or toxicology service must include timing of antidote, last osmolal/anion gap, and hemodialysis status.
Following initial resuscitation and stabilization, definitive ED therapy for suspected toxic alcohol poisoning hinges on early administration of alcohol dehydrogenase inhibitors and timely hemodialysis. The osmolal gap, while imperfect, guides empiric treatment before confirmatory levels return.
Step 1: Initial Assessment and Severity Classification
Classify severity based on clinical and laboratory parameters. High anion gap metabolic acidosis (HAGMA) with an elevated osmolal gap (>10-15 mOsm/kg) strongly suggests toxic alcohol exposure [1]B3b[8]D5. Severe poisoning is defined by pH <7.2, osmolal gap >50 mOsm/kg, visual symptoms (methanol), acute kidney injury (ethylene glycol), or CNS/respiratory depression (isopropanol) [12]C4[14]C4[15]C4. Mild cases may have normal pH and only modest gap elevations.
Step 2: First-Line Intervention, Alcohol Dehydrogenase Inhibition
Administer empirically when toxic alcohol poisoning is suspected, ideally within 1 hour of presentation [17]D5. Fomepizole is the recommended antidote; it blocks metabolism of methanol, ethylene glycol, and diethylene glycol to toxic metabolites [14]C4. Dosing follows a standard protocol (loading dose, then maintenance; see drug label for exact regimen). If fomepizole is unavailable, may be used as an alternative inhibitor, targeting a serum ethanol level of 100-150 mg/dL [14]C4. Ethanol requires frequent monitoring and is less well tolerated.
Step 3: Second-Line Intervention, Hemodialysis
Initiate hemodialysis for severe poisoning: pH <7.2, osmolal gap >50 mOsm/kg, renal failure, visual disturbances, or refractory acidosis despite fomepizole [14]C4[15]C4. Hemodialysis effectively removes methanol, ethylene glycol, and their toxic metabolites (formate, oxalate) [14]C4. In isopropanol poisoning, hemodialysis enhances elimination of both isopropanol and acetone and should be reserved for life-threatening cases with profound CNS depression or circulatory collapse [9]D5. Target hemodialysis initiation within 4-6 hours of diagnosis if criteria are met [14]C4.
Step 4: Monitoring and Titration
Monitor serum osmolal gap, anion gap, arterial blood gas, electrolytes, and renal function every 2-4 hours during therapy [15]C4. The osmolal gap should decrease as toxic alcohol is metabolized or removed. If the gap fails to decline or acidosis worsens, reassess for ongoing absorption or inadequate hemodialysis. Continue fomepizole until toxic alcohol levels are undetectable or below toxic thresholds (see drug label).
Step 5: Resolution, Transition, and Handoff
Discontinue fomepizole when confirmatory levels are negative or below toxic range. Admit all patients with confirmed toxic alcohol poisoning to an ICU for continued monitoring and potential hemodialysis [5]D5. Structured handoff to the admitting service (medical toxicology, nephrology, or critical care) should include: time of fomepizole administration, last osmolal gap and anion gap values, hemodialysis status, and any end-organ complications (e.g., AKI, visual loss). For mild cases with low suspicion and normal gaps, observation in the ED for 6-8 hours with serial labs may suffice before discharge.
Figure 1: ED management algorithm for suspected toxic alcohol poisoning (adapted from [14]C4[15]C4[17]D5).
Controversies and Guideline Disagreement
| Question | Position A | Position B | Strength | Implication for practice |
|---|---|---|---|---|
| Empiric fomepizole in suspected poisoning | US Poison Centers, frequent empiric use (60% of administrations for toxic alcohols) [17]D5 | Critics, high cost ($1.5-2.5 million annually) and many non-toxic alcohol exposures receive it [17]D5 | Moderate | Empiric fomepizole is justified when suspicion is high; rapid confirmatory testing could reduce unnecessary use [17]D5. |
| Role of osmolal gap in diagnosis | Traditional teaching, elevated OG is a key clue [8]D5 | Recent evidence, OG may be normal in up to 30% of toxic alcohol poisonings, especially late presentations [8]D5[10]C4 | Strong | Do not rely solely on OG; use clinical context and serial anion gap [8]D5. |
Pearl: Empiric fomepizole should be administered within 1 hour of presentation when toxic alcohol poisoning is suspected, as delays increase mortality; hemodialysis is reserved for severe cases with metabolic acidosis or end-organ damage [14]C4[15]C4[17]D5.
| Intervention | Indication | Key Details | Evidence |
|---|---|---|---|
| Suspected methanol, EG, DEG poisoning | Loading dose then maintenance (see label); administer within 1 hour [17]D5 | [14]C4[17]D5 | |
| Alternative if fomepizole unavailable | Target serum ethanol 100-150 mg/dL; requires frequent monitoring [14]C4 | [14]C4 | |
| Severe poisoning: pH <7.2, OG >50, AKI, visual loss, refractory acidosis | Initiate within 4-6 hours; removes toxic alcohols and metabolites [14]C4[15]C4 | [14]C4[15]C4 |
History and Evolution of Treatment
- ▸The osmolal gap was first used as a diagnostic clue for ethylene glycol poisoning in 1981, establishing the classic triad of high anion gap, high osmolal gap, and crystalluria [39].
- ▸Recognition of false positives (icodextrin, propylene glycol, alcoholic ketoacidosis, multiple myeloma) led to a higher diagnostic threshold (>25 mOsm/kg) and more cautious interpretation [42,40,41,43,35].
- ▸The therapeutic shift from ethanol to fomepizole as the preferred ADH inhibitor, and the restriction of hemodialysis to severe cases, was guided by improved understanding of the osmolal gap's limitations [14,8].
From the first description of the osmolal gap as a diagnostic clue in ethylene glycol poisoning in 1981 [39]C4, its role in guiding emergent therapy has evolved through successive refinements and cautionary observations. The following timeline traces how the osmolal gap became embedded in toxicologic decision-making, which thresholds were adopted and later challenged, and how the therapeutic response shifted from empiric hemodialysis to targeted antidote use.
Early Recognition and the Osmolal Gap as a Triage Tool (1980s-1990s)
The seminal 1981 case report of a comatose man with ethylene glycol poisoning demonstrated that the combination of a high anion gap metabolic acidosis, a high osmolal gap, and oxalate crystalluria could rapidly identify toxic alcohol ingestion before confirmatory levels returned [39]C4. This triad became the emergency physician's bedside screen. In 1988, a patient with status epilepticus was found to have propylene glycol poisoning solely because of an elevated plasma osmolal gap on admission; the authors urged that osmolality and the osmolal gap be considered first-line investigations in patients with metabolic acidosis and cerebral signs [44]C4. By 1996, Höjer proposed a higher reference limit of >25 mOsm/kg as a strong indicator of methanol or ethylene glycol intoxication in patients with an increased anion gap acidosis, arguing that the traditional cutoff generated too many false positives in alcoholics [42]D5.
Expansion of Causes and the Need for Discernment (1997-2010)
The 1997 icodextrin study in peritoneal dialysis patients revealed that the osmolal gap could rise to an average of 11.8 ± 1.7 mOsm/kg (p < 0.01) from icodextrin metabolites alone, without clinical toxicity [40]A1b. This was the first systematic demonstration that a non-toxic, therapeutic substance could elevate the gap. Subsequently, case reports linked propylene glycol (PG) - a vehicle in intravenous lorazepam and pentobarbital - to an elevated osmolal gap, anion gap metabolic acidosis, and hyperlactatemia. In one patient receiving >40 times the acceptable PG dose over 72 hours, cessation of lorazepam reversed all abnormalities [41]C4. A similar pattern occurred with continuous pentobarbital infusion (40% v/v PG) [27]C4. In 2010, Prevost et al. reported two episodes of alcoholic ketoacidosis (AKA) that presented with the classic triad of azotemia, elevated osmolal gap, and high anion gap metabolic acidosis, yet contained only ethanol, acetone, and isopropanol - no methanol or ethylene glycol [43]C4. This underscored that AKA could mimic toxic alcohol poisoning and required only volume repletion, not antidotes or dialysis.
Refinement of Diagnostic Thresholds and Therapeutic Decision-Making (2010s)
By 2015, Kraut systematically reviewed the limitations of the osmolal gap: it is not always elevated in toxic alcohol poisoning, depending on time of exposure, co-ingestion of ethanol, and the specific alcohol [8]D5. The same review highlighted that definitive detection by gas or liquid chromatography is laborious and often unavailable, spurring interest in rapid enzymatic or colorimetric tests [8]D5. In methanol intoxication, treatment evolved from ethanol infusion (with its attendant intoxication and need for frequent monitoring) to fomepizole, a safer alcohol dehydrogenase inhibitor with predictable pharmacokinetics [14]C4. Hemodialysis was reserved for patients with severe acidosis, high methanol levels, or end-organ damage [14]C4. Among 68 admissions for methanol inhalation, 81% had an osmolal gap ≥10 mOsm/L and all visual symptoms resolved with prompt antidote and supportive care [32]D5.
Contemporary Challenges and False Positives (2020s)
Recent reports have further expanded the differential. A 2023 case demonstrated that can produce an elevated osmolal gap in the absence of any toxic alcohol [35]C4. More concerning, a 2023 pediatric outbreak of ethylene glycol and diethylene glycol intoxication in Indonesia found that no patient had a high osmolal gap (mean 3.46 ± 4.68 mOsm/kg), yet mortality was 37.5% [10]C4. This sobering observation confirms that a normal osmolal gap does not exclude toxic alcohol poisoning, especially when presentation is delayed or the alcohol has been metabolized.
Key Therapeutic Shifts
- From ethanol to fomepizole: Fomepizole replaced ethanol as the preferred ADH inhibitor because it does not cause sedation or hypoglycemia and requires less intensive monitoring [14]C4.
- Hemodialysis reserved for severe cases: Indications include methanol or ethylene glycol levels >50 mg/dL, severe metabolic acidosis (pH <7.25-7.30), or evidence of end-organ damage [14]C4.
- Supportive care alone for isopropanol and AKA: Isopropanol poisoning primarily requires respiratory and cardiovascular support; hemodialysis is reserved for life-threatening cases [9]D5. AKA resolves with intravenous fluids, glucose, and thiamine [42]D5.
Pearl: The osmolal gap is a dynamic, time-sensitive tool - a normal gap does not rule out toxic alcohol poisoning, especially in late presenters or after metabolism to organic acids [10]C4[8]D5. Always interpret it alongside the anion gap, clinical history, and, when available, direct alcohol levels.
| Year | Observation | Impact on Practice |
|---|---|---|
| 1981 | Ethylene glycol poisoning diagnosed by high osmolal gap + anion gap + crystalluria [39]C4 | Established the osmolal gap as a bedside triage tool for toxic alcohols |
| 1988 | Propylene glycol poisoning identified solely by elevated osmolal gap [44]C4 | Expanded the differential to include drug vehicles |
| 1996 | Proposed cutoff >25 mOsm/kg for toxic alcohol suspicion [42]D5 | Reduced false positives in alcoholics |
| 1997 | Icodextrin metabolites elevate osmolal gap without toxicity [40]A1b | First demonstration of a non-toxic therapeutic cause |
| 2001 | Propylene glycol from lorazepam infusion causes elevated osmolal gap and lactic acidosis [41]C4 | Highlighted iatrogenic causes in ICU patients |
| 2010 | Alcoholic ketoacidosis mimics toxic alcohol triad [43]C4 | Emphasized need for volume repletion over antidotes |
| 2015 | Systematic review of limitations: osmolal gap not always elevated [8]D5 | Prompted development of rapid diagnostic tests |
| 2023 | Multiple myeloma as a cause of elevated osmolal gap [35]C4 | Expanded non-toxic differential |
| 2023 | EG/DEG outbreak with normal osmolal gap and 37.5% mortality [10]C4 | Confirmed that a normal gap does not exclude poisoning |
Disposition and Safe Discharge
- ▸Any patient with suspected toxic alcohol ingestion and an elevated osmolal gap should be admitted, with most requiring critical care (67.7% in one series) [17].
- ▸Delayed metabolic acidosis can occur up to 6 hours after presentation, necessitating a period of observation with serial anion and osmolal gaps [15].
- ▸Lack of available emergency hemodialysis is a key driver for transfer to a dialysis-capable center [12].
The decision to admit, observe, or discharge a patient with an elevated serum osmolal gap hinges on the underlying cause, the presence of metabolic acidosis, and the availability of definitive therapy. Because toxic alcohol poisoning can progress rapidly to irreversible organ damage, a low threshold for admission is warranted.
Admission Criteria
Any patient with a suspected toxic alcohol ingestion (methanol, ethylene glycol, isopropanol) and an elevated osmolal gap should be admitted, regardless of the initial anion gap or pH. In a 12-year analysis of fomepizole use reported to US poison centers, 67.7% of all patients receiving the antidote were managed in a critical care unit [17]D5. This reflects the unpredictable trajectory of these poisonings and the need for close monitoring. Patients with a high anion gap metabolic acidosis (HAGMA) and an elevated osmolal gap require immediate ICU admission for antidote administration and possible hemodialysis.
Observation Pathways
For patients with an elevated osmolal gap but a normal anion gap, no acidosis, and no symptoms, a period of observation is prudent. Delayed metabolic acidosis can occur: in one case, a patient with initial normal anion gap (12.8) developed severe HAGMA (anion gap 25.5) and an osmolal gap of 83 six hours after ingestion [15]C4. Serial measurement of the anion and osmolal gaps every 2-4 hours for at least 6-12 hours is recommended. If the gaps remain normal and the patient remains asymptomatic, discharge may be considered after psychiatric evaluation if the ingestion was intentional.
Transfer Criteria
Timely access to hemodialysis is critical for methanol and ethylene glycol poisoning. Challenges to treatment of , especially in rural areas, include lack of available emergency hemodialysis without transfer of the patient [12]C4. If the treating facility cannot provide hemodialysis, the patient should be transferred to a center with that capability as soon as the diagnosis is suspected. Initiation of fomepizole or ethanol should not be delayed pending transfer.
Discharge Criteria
Validated discharge criteria for toxic alcohol poisoning are not established, but clinical resolution guides decision-making. The patient should have:
- Resolution of metabolic acidosis (serum bicarbonate ≥20 mmol/L, normal anion gap)
- Normalization of the osmolal gap (typically <10 mOsm/kg)
- No neurologic or visual symptoms
- Completion of antidote therapy (if indicated)
- Psychiatric clearance for intentional ingestions
In one reported case, a patient with methanol poisoning was discharged nine days after admission without sequelae following hemodialysis and normalization of serum bicarbonate [15]C4.
Return Precautions
Patients discharged after observation or treatment should be instructed to return immediately for any recurrence of visual changes, confusion, abdominal pain, or dyspnea. Because acetone (from isopropanol) has a long elimination half-life (7.7-27 hours), patients with isopropanol poisoning may have prolonged ketonuria and should be counseled accordingly [9]D5.
Disposition Decision Guide
| Clinical Scenario | Recommended Disposition | Rationale |
|---|---|---|
| Suspected toxic alcohol ingestion + elevated osmolal gap + HAGMA | ICU admission | High risk of rapid deterioration; requires antidote and possibly hemodialysis [17]D5 |
| Suspected toxic alcohol ingestion + elevated osmolal gap + normal AG, no acidosis | Observation unit or telemetry for 6-12 hours with serial labs | Delayed acidosis can occur [15]C4 |
| Elevated osmolal gap due to ethanol alone (ethanol detected, no toxic alcohol suspected) | Discharge if ethanol level declining, no acidosis, and patient clinically sober | Ethanol does not cause metabolic acidosis; osmolal gap resolves as ethanol clears [20]D5 |
| Toxic alcohol confirmed + no hemodialysis available | Transfer to dialysis-capable center after starting fomepizole | Lack of timely hemodialysis is a major barrier to survival [12]C4 |
| Isopropanol poisoning with CNS depression or hemodynamic instability | ICU admission | Supportive care is mainstay; hemodialysis reserved for severe cases [9]D5 |
Pearl: The single most important disposition rule is that an elevated osmolal gap with any degree of metabolic acidosis mandates ICU admission, do not wait for confirmatory toxic alcohol levels, as delays in treatment increase mortality [8]D5.
Complications and Pitfalls
- ▸Propylene glycol from lorazepam or pentobarbital can cause bradyarrhythmia and lactic acidosis; discontinuation and hemodialysis are key.
- ▸Ethylene glycol poisoning can cause osmotic demyelination syndrome independent of sodium; controlled osmolality correction is essential.
- ▸Pseudohyponatremia and multiple myeloma are non-toxic causes of elevated osmolal gap that must be considered to avoid mismanagement.
Even after appropriate disposition, the patient with an elevated osmolal gap remains at risk for several complications, and the diagnostic process itself harbors pitfalls that can lead to mismanagement.
Autonomic Complications
Bradyarrhythmia is a life-threatening complication of (PG) intoxication. In a case of -induced PG intoxication, severe bradyarrhythmia developed in the setting of double gap metabolic acidosis [23]C4. Discontinuation of the offending agent and emergent effectively resolved the derangement [23]C4. PG toxicity should be suspected in any patient receiving continuous infusion of PG-containing drugs such as lorazepam or ; the latter has been associated with anion gap metabolic acidosis, elevated lactate, hyperosmolality, and increased osmolal gap [27]C4.
Osmotic Demyelination Syndrome
Massive (EG) poisoning can trigger (ODS) independent of serum sodium levels. In a case with a plasma EG concentration of 1055.5 mg/dL and an osmolal gap of 218, ODS complicated the hospital course despite elevated sodium [46]C4. Rapid changes in serum osmolality from EG toxicity or its treatment are the proposed mechanism [46]C4. Prevention relies on controlled correction of osmolality and early hemodialysis.
Renal Complications
Repetitive EG poisoning can lead to calcium oxalate crystal deposition in the kidneys, as confirmed on autopsy in a patient with 154 admissions [31]C4. Despite repeated episodes, kidney function normalized after each overdose in that case, but acute kidney injury remains a risk [31]C4. Early administration of and hemodialysis is the mainstay of prevention.
Metabolic Complications
(AKA) can present with the triad of azotemia, elevated osmolal gap, and high anion gap metabolic acidosis, mimicking toxic alcohol poisoning [43]C4. In AKA, volume repletion alone rapidly reverses the acidosis, and finding 2-propanol in serum indicates either concomitant ingestion or formation from acetone [43]C4. Misdiagnosis as EG or could lead to unnecessary antidote administration and dialysis.
Pitfalls in Interpretation
from hypergammaglobulinemia (e.g., HIV/HCV coinfection) or hyperlipidemia leads to a falsely low calculated serum osmolality, thereby elevating the osmolal gap [25]C4. Clinicians must know their laboratory's method for sodium measurement; if indirect ion-selective electrode is used, pseudohyponatremia can occur [25]C4. Similarly, in idiopathic nephrotic syndrome with severe edema, an increased osmolal gap may be due to non-Na⁺ and non-K⁺ osmoles, and fluid restriction could precipitate pre-renal failure [33]D5.
is another cause of elevated osmolal gap that should be considered when toxic alcohol ingestion is not confirmed [35]C4. In a case of altered mental status with elevated gap, the patient was treated with fomepizole and hemodialysis, but the gap was ultimately attributed to multiple myeloma [35]C4.
Complication Table
| Complication | Frequency | Prevention | Management |
|---|---|---|---|
| Bradyarrhythmia (PG toxicity) | Not reported | Avoid high-dose PG-containing infusions; monitor osmolal gap | Discontinue PG source; hemodialysis [23]C4 |
| Osmotic demyelination syndrome (EG) | Not reported | Controlled osmolality correction; early hemodialysis | Supportive care [46]C4 |
| Acute kidney injury (EG) | Not reported | Early fomepizole and hemodialysis | Dialysis as needed [31]C4 |
| (PG) | Not reported | Monitor for anion gap acidosis | Discontinue PG source [27]C4 |
| Alcoholic ketoacidosis misdiagnosis | Not reported | Consider AKA in alcoholics with elevated gap | Volume repletion [43]C4 |
| Pseudohyponatremia-induced gap | Not reported | Know lab method; consider in hyperproteinemia | Treat underlying cause [25]C4 |
| Multiple myeloma gap | Not reported | Include in differential when toxic alcohols absent | Treat myeloma [35]C4 |
Pearl: An elevated osmolal gap does not always signify toxic alcohol poisoning; always consider propylene glycol toxicity, pseudohyponatremia, alcoholic ketoacidosis, and multiple myeloma before committing to fomepizole and dialysis.
Prognosis and Natural History
- ▸Mortality from methanol poisoning can reach 100% even with maximal treatment if diagnosis is delayed; early recognition is critical [12].
- ▸Ethylene glycol/diethylene glycol intoxication may present with a normal osmolal gap, yet carry a 37.5% mortality rate [10].
- ▸Timely administration of fomepizole and hemodialysis can lead to full recovery without sequelae [15].
The prognosis of patients with an elevated osmolal gap hinges on the underlying cause and the timeliness of intervention. For toxic alcohol poisoning, the most critical scenario, the natural history follows a predictable but time-sensitive course. After ingestion, a latent period of a few hours to a few days occurs before toxic metabolites accumulate, producing symptoms such as abdominal pain, visual loss, and altered consciousness [14]C4. Without treatment, cellular dysfunction progresses rapidly to severe metabolic acidosis, acute kidney injury, and death [5]D5[8]D5.
Mortality and Outcomes
Mortality rates are substantial when diagnosis is delayed. In a series of five patients with from contaminated hand sanitizer, all five died despite maximal treatment including fomepizole and hemodialysis [12]C4. In a pediatric outbreak of ethylene glycol and diethylene glycol intoxication, mortality was 37.5% (6 of 16 patients) [10]C4. Notably, in that cohort the mean osmolal gap was only 3.46 ± 4.68 mOsm/kg, within the normal range, underscoring that a normal gap does not rule out poisoning and may delay recognition, worsening prognosis [10]C4. Conversely, with early detection and intervention, outcomes can be excellent: one patient with methanol poisoning (serum level 193.8 mg/dL) who received high-flux hemodialysis within hours was discharged without sequelae [15]C4.
Isopropanol poisoning carries a lower mortality risk; deaths are rare, and patients usually make a full recovery with prompt supportive care [9]D5. However, severe cases can cause CNS and respiratory depression, shock, and circulatory collapse [9]D5.
Factors Influencing Prognosis
Several factors determine outcome:
- Time to treatment: Early administration of fomepizole or ethanol (alcohol dehydrogenase inhibitors) and timely hemodialysis markedly improve survival [8]D5[14]C4.
- Availability of laboratory testing: Lack of rapid methanol or ethylene glycol assays forces empiric therapy; fomepizole is used in many non-toxic alcohol exposures, costing an estimated $1.5-$2.5 million annually, but this practice reflects diagnostic uncertainty rather than improved outcomes [17]D5.
- Co-ingestion of ethanol: Ethanol competitively inhibits alcohol dehydrogenase, slowing toxic metabolite formation and potentially improving prognosis [14]C4.
- Renal function: In patients with preserved renal function, the urine osmolal gap can help distinguish renal tubular acidosis from extrarenal bicarbonate loss, but RTA itself was not associated with increased mortality in critically ill patients [2]B3b.
Pearl: A normal osmolal gap does not exclude toxic alcohol poisoning, in one outbreak, all patients had a mean gap <5 mOsm/kg yet mortality was 37.5% [10]C4. When clinical suspicion is high, treat empirically and obtain definitive chromatography; waiting for the gap to rise can be fatal.
Special Populations and Pregnancy
- ▸The urine osmolal gap (UOG) is validated in moderate to severe CKD (mean age 72 years) but overestimates urinary ammonium by ~4.7 mmol/L [18].
- ▸No pediatric- or pregnancy-specific validation of osmolal gap formulas exists in the reviewed literature; use adult cutoffs cautiously.
- ▸Autoimmune diseases such as Sjögren syndrome are established causes of distal RTA and should be considered in immunocompromised patients with unexplained hyperchloremic acidosis [45].
Prognosis depends on timely recognition, but the diagnostic pathway must be adapted for hosts where standard thresholds and treatments carry unique risks. The serum osmolal gap and urine osmolal gap (UOG) retain their utility across special populations, but interpretation requires population-specific adjustments.
Pediatrics
No pediatric-specific studies were identified in the reviewed literature. The same formulas for calculated osmolality and UOG apply, but clinicians should be aware that normal reference ranges for serum osmolality and the osmolal gap may differ in children due to lower baseline urea and glucose concentrations. The UOG threshold of 150 mosmol/kg used to distinguish renal tubular acidosis (RTA) from extrarenal bicarbonate loss [2]B3b has not been validated in pediatric cohorts. Until pediatric data emerge, use adult cutoffs cautiously and interpret in the context of age-appropriate electrolyte norms.
Pregnancy
Physiologic changes in pregnancy, plasma volume expansion, dilutional hyponatremia, increased glomerular filtration rate, and , alter the baseline values of sodium, urea, and bicarbonate used in osmolal gap calculations. No studies in the reviewed evidence specifically address the osmolal gap in pregnancy. The UOG formula (calculated urine osmolality = (2 × (Na+ + K+)) + (urea nitrogen in mg/dL)/2.8 + (glucose in mg/dL)/18) [2]B3b has not been validated in pregnant patients. When evaluating metabolic acidosis in pregnancy, the osmolal gap should be interpreted with attention to gestational age and concurrent acid-base disturbances. Treatment of toxic alcohol poisoning (e.g., methanol, ethylene glycol) with hemodialysis and antidotes (fomepizole, ethanol) must weigh maternal benefit against fetal risk, but specific outcome data are absent from the reviewed sources.
Elderly
In elderly patients, chronic kidney disease (CKD) is common and alters the interpretation of the UOG. A study of 36 patients with non-dialysis-dependent CKD (mean age 72.0 ± 14.8 years, mean serum creatinine 2.7 ± 2.3 mg/dL) found a strong correlation between UOG/2 and measured urinary ammonium concentration (r = 0.925) [18]D5. However, U-NH4+ estimated using the UOG was on average higher by 4.7 mmol/L than the measured value [18]D5. This suggests that while UOG is a useful surrogate for urinary ammonium in moderate to severe CKD, it may overestimate ammonium excretion. The traditional UOG cutoff of <150 mosmol/kg for diagnosing RTA requires preserved renal function (glomerular filtration rate >25 mL/min) [2]B3b; in elderly patients with reduced GFR, a low UOG may reflect impaired ammonium excretion rather than RTA. The osmolal gap for toxic alcohol screening should be interpreted with caution because age-related reductions in muscle mass lower baseline creatinine and may affect the anion gap calculation.
Immunocompromised
Autoimmune diseases are a recognized cause of distal renal tubular acidosis (type 1 RTA). Sjögren syndrome, in particular, is associated with RTA presenting as normal anion gap metabolic acidosis [45]C4. In immunocompromised patients, including those with HIV, transplant recipients, or those on immunosuppressive therapy, the differential for elevated osmolal gap and high anion gap metabolic acidosis should include drug-induced tubular injury (e.g., , ) and opportunistic infections, although these specific etiologies were not addressed in the reviewed evidence. The UOG remains the preferred method to evaluate hyperchloremic acidosis in critically ill patients because it is not invalidated by increased excretion of unmeasured anions [2]B3b. In immunocompromised hosts with unexplained metabolic acidosis, a low UOG (<150 mosmol/kg) with preserved renal function should prompt evaluation for RTA, including autoimmune serologies.
Pearl: In elderly patients with CKD, the urine osmolal gap overestimates urinary ammonium by about 5 mmol/L [18]D5; use a higher threshold (e.g., UOG <200 mosmol/kg) when screening for renal tubular acidosis in this population, and always confirm with direct ammonium measurement when available.
Prevention, Screening and ED-Based Interventions
- ▸Primary prevention relies on regulatory oversight of hand sanitizers and medications, as demonstrated by methanol-contaminated sanitizers during COVID-19 [12] and EG/DEG in pediatric syrups [10].
- ▸Screening with the osmolal gap is imperfect; a normal gap does not exclude toxic alcohol poisoning, and empiric fomepizole is frequently administered for non-toxic alcohol exposures [17].
- ▸ED-based tertiary prevention includes patient education on safe storage, symptom recognition, and mental health referral for intentional ingestions.
Having addressed the distinct challenges in pregnant patients and children, the emergency clinician must recognize that each encounter with suspected toxic alcohol exposure is also a public health touchpoint. The serum osmolal gap, despite its limitations, remains the most accessible screening tool in the ED, and its use can be leveraged across three prevention tiers.
Primary Prevention: Reducing Exposure to Toxic Alcohols
Primary prevention targets the root causes of poisoning. The pandemic exposed a critical regulatory gap: hand sanitizers containing methanol instead of ethanol or isopropanol led to a 124% increase in exposures and five deaths in one series [12]C4. Clinicians should report suspected contaminated products to local poison centers and the FDA. In pediatric populations, the 2022 Indonesian outbreak of ethylene glycol and diethylene glycol (EG/DEG) poisoning from syrup-based medications caused rapidly progressive AKI in 16 children, with 37.5% mortality [10]C4. Public health measures, including mandatory testing of pharmaceutical excipients and restricting sales of non-beverage alcohols, are essential. No vaccine exists for toxic alcohol poisoning; prevention relies entirely on regulatory oversight and community education.
Secondary Prevention: Screening and Early Detection
Screening for toxic alcohol exposure begins with a high index of suspicion. The osmolal gap is the first-line surrogate test, but it has important limitations: an elevated gap is not always present, and a normal gap does not rule out poisoning [8]D5. The 2021 AJKD Core Curriculum recommends calculating the osmolal gap in any patient with unexplained high anion gap metabolic acidosis (HAGMA) and a history suggesting ingestion [11]C4. A simplified formula, 2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol, improves diagnostic accuracy compared with older equations [1]B3b. In patients with detectable ethanol, the 95% range of osmolal gap values narrowed to -10.9 to 13.8 mOsm/kg [1]B3b. Frequent serial monitoring of both anion and osmolal gaps can detect delayed presentations, as illustrated by a case where gaps rose from normal to 25.5 and 83, respectively, 6 hours after ingestion [15]C4. Empiric administration of fomepizole is common, 25,110 uses reported over 12 years, but 40% of administrations were for non-toxic alcohol exposures, highlighting the need for better rapid diagnostics [17]D5.
Tertiary Prevention: Preventing Recurrence and Patient Education
After stabilization and treatment, the ED visit is an opportunity to prevent re-exposure. Patient education should include:
- Avoiding non-beverage alcohols: Rubbing alcohol (isopropanol), antifreeze, and windshield washer fluid are common sources [9]D5.
- Safe storage: Keep products in original containers, out of reach of children.
- Recognizing symptoms: Early signs include inebriation without ethanol use, visual changes (methanol), and oxalate crystals in urine (ethylene glycol).
- Reporting exposures: Contact poison control (1-800-222-1222 in the US) for any suspected ingestion.
For patients with intentional ingestions, a mental health evaluation and referral for substance use disorder treatment are critical to prevent recurrence. The 2022 AJKD Core Curriculum emphasizes that timely hemodialysis and enzyme inhibition (fomepizole or ethanol) improve outcomes, but only if initiated early [5]D5.
Pearl: When screening for toxic alcohol poisoning, use the simplified formula 2.0×Na + 1.2×Urea + 1.4×Glucose + 1.2×Ethanol [1]B3b; a gap >10 mOsm/kg in the absence of ethanol or other known osmoles warrants empiric fomepizole while awaiting confirmatory testing.
References
- [1]
Lepeytre F, Ghannoum M, Ammann H et al.. “Formulas for Calculated Osmolarity and Osmolal Gap: A Study of Diagnostic Accuracy.” American journal of kidney diseases : the official journal of the National Kidney Foundation (2017). PMID: 28578820 ↗
L3RETROSPECTIVE_COHORTCited in: Definition, Classification and Nomenclature, Clinical Presentation, The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [2]
Brunner R, Drolz A, Scherzer TM et al.. “Renal tubular acidosis is highly prevalent in critically ill patients.” Critical care (London, England) (2015). PMID: 25888397 ↗
L3COHORTCited in: Definition, Classification and Nomenclature, Epidemiology, Etiology and Risk Factors, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Complications and Pitfalls, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions - [3]
Greenberg KI, Lecker SH. “Metabolic Acidosis.” Advances in kidney disease and health (2025). PMID: 40175031 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Epidemiology, Etiology and Risk Factors, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [4]
Büyükkaragöz B, Bakkaloğlu SA. “Serum osmolality and hyperosmolar states.” Pediatric nephrology (Berlin, Germany) (2022). PMID: 35779183 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [5]
Mullins ME, Kraut JA. “The Role of the Nephrologist in Management of Poisoning and Intoxication: Core Curriculum 2022.” American journal of kidney diseases : the official journal of the National Kidney Foundation (2021). PMID: 34895948 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Epidemiology, Etiology and Risk Factors, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [6]
Berend K, Duits AJ. “The role of the clinical laboratory in diagnosing acid-base disorders.” Critical reviews in clinical laboratory sciences (2019). PMID: 30917291 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions - [7]
Berend K. “Review of the Diagnostic Evaluation of Normal Anion Gap Metabolic Acidosis.” Kidney diseases (Basel, Switzerland) (2017). PMID: 29344509 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [8]
Kraut JA. “Diagnosis of toxic alcohols: limitations of present methods.” Clinical toxicology (Philadelphia, Pa.) (2015). PMID: 26114345 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [9]
Slaughter RJ, Mason RW, Beasley DM et al.. “Isopropanol poisoning.” Clinical toxicology (Philadelphia, Pa.) (2014). PMID: 24815348 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [10]
Hidayati EL, Fahlevi R, Puspitasari HA et al.. “Emerging progressive atypical acute kidney injury in young children linked to ethylene glycol and diethylene glycol intoxication.” Pediatric nephrology (Berlin, Germany) (2023). PMID: 37755463 ↗
L4CROSS_SECTIONALCited in: Definition, Classification and Nomenclature, Epidemiology, Etiology and Risk Factors, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [11]
Fenves AZ, Emmett M. “Approach to Patients With High Anion Gap Metabolic Acidosis: Core Curriculum 2021.” American journal of kidney diseases : the official journal of the National Kidney Foundation (2021). PMID: 34400023 ↗
L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions - [12]
Holzman SD, Larsen J, Kaur R et al.. “Death by hand sanitizer: syndemic methanol poisoning in the age of COVID-19.” Clinical toxicology (Philadelphia, Pa.) (2021). PMID: 33755514 ↗
L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [13]
Rastegar M, Nagami GT. “Non-Anion Gap Metabolic Acidosis: A Clinical Approach to Evaluation.” American journal of kidney diseases : the official journal of the National Kidney Foundation (2016). PMID: 28029394 ↗
L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions - [14]
Kraut JA. “Approach to the Treatment of Methanol Intoxication.” American journal of kidney diseases : the official journal of the National Kidney Foundation (2016). PMID: 27180631 ↗
L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, History and Evolution of Treatment, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [15]
Hsiao PJ, Chen TY, Chiu CC et al.. “Delayed high anion gap metabolic acidosis after a suicide attempt: case report.” Clinica chimica acta; international journal of clinical chemistry (2014). PMID: 24992526 ↗
L4CASE_SERIESCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions - [16]
Rasouli M. “Basic concepts and practical equations on osmolality: Biochemical approach.” Clinical biochemistry (2016). PMID: 27343561 ↗
L5NARRATIVE_REVIEWCited in: Definition, Classification and Nomenclature - [17]
Leonard JB, Minhaj FS, Erickson K et al.. “Fomepizole use reported to United States Poison Centers from 2010 to 2021.” Clinical toxicology (Philadelphia, Pa.) (2024). PMID: 38465690 ↗
L5OTHERCited in: Definition, Classification and Nomenclature, Clinical Presentation, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [18]
Fujimaru T, Shuo T, Nagahama M et al.. “Assessing urine ammonium concentration by urine osmolal gap in chronic kidney disease.” Nephrology (Carlton, Vic.) (2021). PMID: 34288275 ↗
L5OTHERCited in: Definition, Classification and Nomenclature, Mechanisms of the Dangerous Differential, Clinical Presentation, The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Special Populations and Pregnancy, Prevention, Screening and ED-Based Interventions - [19]
Ebonwu EO, Nagel SE, Repsold L et al.. “Critical evaluation of equations for serum osmolality: Proposals for effective clinical utility.” Clinica chimica acta; international journal of clinical chemistry (2020). PMID: 32622969 ↗
L5OTHERCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [20]
Nguyen MK, Song L, Kao L et al.. “Is the Osmolal Concentration of Ethanol Greater Than Its Molar Concentration?” Frontiers in medicine (2020). PMID: 31970159 ↗
L5OTHERCited in: Definition, Classification and Nomenclature, Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [21]
Latus J, Kimmel M, Alscher MD et al.. “Ethylene glycol poisoning: a rare but life-threatening cause of metabolic acidosis-a single-centre experience.” Clinical kidney journal (2012). PMID: 25503773 ↗
L4COHORTCited in: Mechanisms of the Dangerous Differential - [22]
Kraut JA, Kurtz I. “Toxic alcohol ingestions: clinical features, diagnosis, and management.” Clinical journal of the American Society of Nephrology : CJASN (2007). PMID: 18045860 ↗
L5NARRATIVE_REVIEWCited in: Mechanisms of the Dangerous Differential, Clinical Presentation - [23]
Tsao YT, Tsai WC, Yang SP. “A life-threatening double gap metabolic acidosis.” The American journal of emergency medicine (2008). PMID: 18358977 ↗
L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, Clinical Presentation, Complications and Pitfalls - [24]
Shull PD, Rapoport J. “Life-threatening reversible acidosis caused by alcohol abuse.” Nature reviews. Nephrology (2010). PMID: 20644581 ↗
L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, History and Evolution of Treatment, Complications and Pitfalls - [25]
Garibaldi BT, Cameron SJ, Choi M. “Pseudohyponatremia in a patient with HIV and hepatitis C coinfection.” Journal of general internal medicine (2007). PMID: 17994269 ↗
L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, Complications and Pitfalls - [26]
Kamel KS, Halperin ML. “An improved approach to the patient with metabolic acidosis: a need for four amendments.” Journal of nephrology (2006). PMID: 16736445 ↗
L5NARRATIVE_REVIEWCited in: Mechanisms of the Dangerous Differential - [27]
Miller MA, Forni A, Yogaratnam D. “Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital.” The Annals of pharmacotherapy (2008). PMID: 18698010 ↗
L4CASE_SERIESCited in: Mechanisms of the Dangerous Differential, History and Evolution of Treatment, Complications and Pitfalls - [28]
Santoso DN, Sinuraya FAG, Ambarsari CG. “Distal renal tubular acidosis presenting with an acute hypokalemic paralysis in an older child with severe vesicoureteral reflux and syringomyelia: a case report.” BMC nephrology (2022). PMID: 35836135 ↗
L4CASE_SERIESCited in: Epidemiology, Etiology and Risk Factors, Complications and Pitfalls - [29]
Krahn J, Khajuria A. “Osmolality gaps: diagnostic accuracy and long-term variability.” Clinical chemistry (2006). PMID: 16455871 ↗
L3COHORTCited in: Clinical Presentation, The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup - [30]
Kraut JA, Xing SX. “Approach to the evaluation of a patient with an increased serum osmolal gap and high-anion-gap metabolic acidosis.” American journal of kidney diseases : the official journal of the National Kidney Foundation (2011). PMID: 21794966 ↗
L4CASE_SERIESCited in: Clinical Presentation - [31]
Hovda KE, Julsrud J, Øvrebø S et al.. “Studies on ethylene glycol poisoning: one patient - 154 admissions.” Clinical toxicology (Philadelphia, Pa.) (2011). PMID: 21824058 ↗
L4CASE_SERIESCited in: Clinical Presentation, Complications and Pitfalls - [32]
Wallace EA, Green AS. “Methanol toxicity secondary to inhalant abuse in adult men.” Clinical toxicology (Philadelphia, Pa.) (2009). PMID: 19012086 ↗
L5OTHERCited in: Clinical Presentation, History and Evolution of Treatment - [33]
Kapur G, Valentini RP, Imam AA et al.. “Serum osmolal gap in patients with idiopathic nephrotic syndrome and severe edema.” Pediatrics (2007). PMID: 17485452 ↗
L5OTHERCited in: Clinical Presentation, Complications and Pitfalls - [34]
Sadilek M, Feldman K, Murray KF et al.. “Detection of polyethylene glycol-based laxatives in stool.” Journal of pediatric gastroenterology and nutrition (2010). PMID: 20118809 ↗
L5OTHERCited in: Clinical Presentation - [35]
Malkan R, Baillio M, Gao HT et al.. “Elevated Osmolal Gap in a Case of Multiple Myeloma.” The Journal of emergency medicine (2023). PMID: 38403563 ↗
L4CASE_SERIESCited in: Clinical Presentation, History and Evolution of Treatment, Complications and Pitfalls - [36]
Coulter CV, Farquhar SE, McSherry CM et al.. “Methanol and ethylene glycol acute poisonings - predictors of mortality.” Clinical toxicology (Philadelphia, Pa.) (2011). PMID: 22091788 ↗
L5NARRATIVE_REVIEWCited in: The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup - [37]
Hunderi OH, Hovda KE, Jacobsen D. “Use of the osmolal gap to guide the start and duration of dialysis in methanol poisoning.” Scandinavian journal of urology and nephrology (2006). PMID: 16452060 ↗
L5OTHERCited in: The Diagnostic Sieve: Worst-First Differential, Rule-Out Rules & Rapid Workup - [38]
Cao D, Maynard S, Mitchell AM et al.. “Point of care testing provides an accurate measurement of creatinine, anion gap, and osmolal gap in ex-vivo whole blood samples with nitromethane.” Clinical toxicology (Philadelphia, Pa.) (2014). PMID: 24844579 ↗
L5OTHERCited in: Severity, Risk Stratification and Triage, Acute Resuscitation and Stabilization, Resuscitative Procedures, Airway Management & Procedural Sedation, Definitive ED Therapy, Time-to-Intervention Targets & Handoff, Disposition and Safe Discharge, Prognosis and Natural History, Prevention, Screening and ED-Based Interventions - [39]
Cadnapaphornchai P, Taher S, Bhathena D et al.. “Ethylene glycol poisoning: diagnosis based on high osmolal and anion gaps and crystalluria.” Annals of emergency medicine (1981). PMID: 7224256 ↗
L4CASE_SERIESCited in: History and Evolution of Treatment - [40]
Posthuma N, ter Wee PM, Donker AJ et al.. “Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.” Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis (1997). PMID: 9655161 ↗
L1RCTCited in: History and Evolution of Treatment - [41]
Cawley MJ. “Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review.” Pharmacotherapy (2001). PMID: 11560204 ↗
L4CASE_SERIESCited in: History and Evolution of Treatment - [42]
Höjer J. “Severe metabolic acidosis in the alcoholic: differential diagnosis and management.” Human & experimental toxicology (1996). PMID: 8793530 ↗
L5NARRATIVE_REVIEWCited in: History and Evolution of Treatment - [43]
Prevost M, Sun Y, Servilla KS et al.. “Repeated intoxication presenting with azotemia, elevated serum osmolal gap, and metabolic acidosis with high anion gap: differential diagnosis, management, and prognosis.” International urology and nephrology (2010). PMID: 20602169 ↗
L4CASE_SERIESCited in: History and Evolution of Treatment, Complications and Pitfalls, Special Populations and Pregnancy - [44]
Lolin Y, Francis DA, Flanagan RJ et al.. “Cerebral depression due to propylene glycol in a patient with chronic epilepsy--the value of the plasma osmolal gap in diagnosis.” Postgraduate medical journal (1988). PMID: 3249707 ↗
L4CASE_SERIESCited in: History and Evolution of Treatment - [45]
Lim AK, Choi MJ. “Distal renal tubular acidosis associated with Sjogren syndrome.” Internal medicine journal (2013). PMID: 24330363 ↗
L4CASE_SERIESCited in: Complications and Pitfalls, Special Populations and Pregnancy - [46]
Ahmed A, Tschetter PA, Krasowski MD et al.. “Massive ethylene glycol poisoning triggers osmotic demyelination syndrome.” The Journal of emergency medicine (2013). PMID: 24199725 ↗
L4CASE_SERIESCited in: Complications and Pitfalls - [47]
Fazekas AS, Funk GC, Klobassa DS et al.. “Evaluation of 36 formulas for calculating plasma osmolality.” Intensive care medicine (2012). PMID: 23081685 ↗
L5OTHERCited in: Special Populations and Pregnancy